{"database":"MetabolomicsWorkbench","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["http://www.metabolomicsworkbench.org/rest/study/study_id/ST001104/mwtab"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Metabolomics"],"technology_type":["Mass Spectrometry","ESI"],"disease":["Tuberculosis"],"species":["Homo Sapiens"],"full_dataset_link":["http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001104"],"study_factor":["Sample Type:Enriched SLC1G after treatment with a2-3,6,8 neuraminidase and O-glycosidase for comparison with seryl-leucine standard","Sample Type:Patient urine","Sample Type:Enriched SLC1G after treatment with a2-3,6,8 neuraminidase and O-glycosidase","Sample Type:Enriched SLC1G after treatment with a2-3 neuraminidase","Sample Type:Seryl-leucine Standard","Sample Type:Enriched SLC1G","Sample Type:Enriched SLC1G after treatment with a2-3,6,8 neuraminidase"],"submitter_affiliation":["Colorado State University"],"tissue":["Urine"],"sample_protocol":["Reversed phase POSITIVE ION MODE/TOF. Reversed phase POSITIVE ION MODE/QTOF."],"repository":["MetabolomicsWorkbench"],"metabolite_name":["Galactose-N-acetylgalactosamine-SL","SLC1G","Ser-Leu","Galactose-N-acetylgalactosamine","N-acetylneuraminic acid"],"data_protocol":[""],"sample_synonyms":["FEZL, VSD1, ZFP312, backward, reversed., TOF, FEZ, TACHD, ZNF312, reversed, ASD2"],"name_synonyms":["L-Leucine, polypeptide, peptide, (RS)-Leucine, Polypeptides, L-Isomer Leucine, peptido, peptides, Leucine, L, DL-Leucine, 2-amino-4-methylpentanoic acid, core, L Isomer, Peptid, peptidos, Leuzin, Polypeptide, Hleu, L-Isomer, (+-)-Leucine, Leucin, Peptide., Leu"],"additional_accession":[]},"is_claimable":false,"name":"Seryl-leucine core 1 O-glycosylated peptide (SLC1G) identification","description":null,"dates":{"publication":""},"accession":"ST001104","cross_references":{"TAXONOMY":["9606"]}}